Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

The latest news for pharma industry insiders.

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.

Trade & Channel Strategies 2024: Key Challenges of Implementing Direct-to-Patient Models ...